Amicus Therapeutics
FOLD
FOLD
226 hedge funds and large institutions have $4.25B invested in Amicus Therapeutics in 2020 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 74 increasing their positions, 74 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
226
Holders Change
+24
Holders Change %
+11.88%
% of All Funds
4.65%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.16%
New
43
Increased
74
Reduced
74
Closed
17
Calls
$43.4M
Puts
$4.23M
Net Calls
+$39.1M
Net Calls Change
+$30M
Top Buyers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$94.4M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
$32.1M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
$101M |
| 4 |
D.E. Shaw & Co
New York
|
$106M |
| 5 |
JPMorgan Chase & Co
New York
|
$121M |
Top Sellers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
$52.9M |
| 2 |
Morgan Stanley
New York
|
$126M |
| 3 |
DM
Deerfield Management
New York
|
$21.4M |
| 4 |
AG
Artal Group
Luxembourg
|
$52.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
$15.4M |
